Awards and Honors
Shana Kelley named Guggenheim Fellow
April 12, 2022
Prestigious fellowship awarded to IIN-affiliated researcher and two colleagues
IIN-affiliated researcher Shana Kelley and Northwestern colleagues Jeffrey Masten and Kimberly Yuracko are among the 2022 Guggenheim Fellows recently named by the John Simon Guggenheim Memorial Foundation.
This year, the Foundation awarded 180 artists, writers, scholars and scientists from across the United States and Canada. Selected from a pool of nearly 2,500 applicants, the fellows were appointed on the basis of prior achievement and exceptional promise.
“Now that the past two years are hopefully behind all of us, it is a special joy to celebrate the Guggenheim Foundation’s new class of Fellows,” said Edward Hirsch, president of the Guggenheim Foundation and 1985 fellow in poetry. “This year marks the Foundation’s 97th annual Fellowship competition. Our long experience tells us what an impact these annual grants will have to change people’s lives. The work supported by the Foundation will aid in our collective effort to better understand the new world we’re in, where we’ve come from, and where we’re going. It is an honor for the Foundation to help the Fellows carry out their visionary work.”
An internationally renowned researcher, Kelley develops innovative and translational methods for tracking molecular and cellular analytes with unprecedented sensitivity. Her novel approaches integrate nanoscience with bioanalytical science and engineering. She also is well-known for developing new methods to detect circulating cancer cells and delivery systems that leverage mitochondrial penetrating peptides and related materials.
With the Guggenheim Fellowship, Kelley will develop a new class of sensors for the human body that will enable continuous monitoring of biochemical markers of health and disease. This type of sensing approach will provide new ways to prevent and manage disease.
“I am deeply grateful for this recognition that reflects the highly creative and hard work of my research team as well as the resources that will enable us to continue innovating and pursuing a positive impact on human health,” Kelley said.